Intellectual Property India Publishes Patent Application for 'Dendritic Cell-Based Vaccines And Uses Thereof' Filed by Mayo Foundation For Medical Education And Research; and Bioventures, Llc

MUMBAI, India, Aug. 29 -- Intellectual Property India has published a patent application (202517076260 A) filed by Mayo Foundation For Medical Education And Research; and Bioventures, Llc, Rochester, U.S.A., on Aug. 11, for 'dendritic cell-based vaccines and uses thereof.'

Inventor(s) include Knutson, Keith L.; Block, Matthew S; Dietz, Allan B.; Gustafson, Michael P.; and Cannon, Martin John.

The application for the patent was published on Aug. 29, under issue no. 35/2025.

According to the abstract released by the Intellectual Property India: "Methods and materials for treating cancer (e.g., ovarian cancer) using a combination of a Th17 DC vaccine, optionally in combination with an immune checkpoint inhibitor, are provided herein."

The patent application was internationally filed on Feb. 07, 2024, under International application No.PCT/US2024/014767.

Disclaimer: Curated by HT Syndication.